Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 1
2006 3
2008 1
2009 2
2010 4
2011 4
2012 7
2013 8
2014 8
2015 10
2016 1
2017 2
2018 2
2019 1
2020 1
2021 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R. Yamaguchi M, et al. Among authors: hashimoto c. J Clin Oncol. 2011 Nov 20;29(33):4410-6. doi: 10.1200/JCO.2011.35.6287. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990393 Clinical Trial.
R-CHOP therapy alone for limited-stage follicular lymphoma.
Tomita N, Suzuki T, Ishiyama Y, Miyashita K, Takahashi H, Numata A, Ito S, Motohashi K, Tachibana T, Takasaki H, Kawasaki R, Hagihara M, Hashimoto C, Yamazaki E, Taguchi J, Fujimaki K, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: hashimoto c. Leuk Res. 2015 Jun;39(6):582-5. doi: 10.1016/j.leukres.2015.03.008. Epub 2015 Apr 6. Leuk Res. 2015. PMID: 25866096 Clinical Trial.
Dissemination pattern of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.
Ishii Y, Tomita N, Suzuki T, Ishiyama Y, Kishimoto K, Yamamoto E, Koyama S, Hattori Y, Nakajima Y, Motohashi K, Takasaki H, Kawasaki R, Hashimoto C, Takemura S, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Motomura S, Ishigatsubo Y. Ishii Y, et al. Among authors: hashimoto c. Leuk Lymphoma. 2015;56(9):2750-2. doi: 10.3109/10428194.2015.1010161. Epub 2015 Mar 6. Leuk Lymphoma. 2015. PMID: 25644745 No abstract available.
Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective Study.
Takahashi H, Sakai R, Sakuma T, Matsumura A, Miyashita K, Ishii Y, Nakajima Y, Numata A, Hattori Y, Miyazaki T, Hashimoto C, Koharazawa H, Takemura S, Taguchi J, Fujimaki K, Fujita H, Nakajima H. Takahashi H, et al. Among authors: hashimoto c. Indian J Hematol Blood Transfus. 2021 Jan;37(1):60-66. doi: 10.1007/s12288-020-01307-7. Epub 2020 Jun 23. Indian J Hematol Blood Transfus. 2021. PMID: 33707836 Free PMC article.
Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.
Tomita N, Taguri M, Hashimoto C, Takasaki H, Fujimaki K, Motomura S, Koharazawa H, Takemura S, Fujita H, Yamazaki E, Kawasaki R, Taguchi J, Sakai R, Fujisawa S, Hattori Y, Kanamori H, Yamamoto W, Harano H, Ogawa K, Ishigatsubo Y. Tomita N, et al. Among authors: hashimoto c. Ann Hematol. 2015 Nov;94(11):1935-7. doi: 10.1007/s00277-015-2448-2. Epub 2015 Jul 25. Ann Hematol. 2015. PMID: 26208667 No abstract available.
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Tomita N, Kodama F, Tsuyama N, Sakata S, Takeuchi K, Ishibashi D, Koyama S, Ishii Y, Yamamoto W, Takasaki H, Hagihara M, Kuwabara H, Tanaka M, Hashimoto C, Yamazaki E, Koharazawa H, Fujimaki K, Sakai R, Fujisawa S, Ishigatsubo Y. Tomita N, et al. Among authors: hashimoto c. Hematol Oncol. 2015 Mar;33(1):9-14. doi: 10.1002/hon.2136. Epub 2014 Feb 11. Hematol Oncol. 2015. PMID: 24519501 Clinical Trial.
Body mass index is a prognostic factor in adult patients with acute myeloid leukemia.
Ando T, Yamazaki E, Ogusa E, Ishii Y, Yamamoto W, Motohashi K, Tachibana T, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Fujita H, Kanamori H, Fujisawa S, Nakajima H; Yokohama Cooperative Study Group for Hematology (YACHT). Ando T, et al. Among authors: hashimoto c. Int J Hematol. 2017 May;105(5):623-630. doi: 10.1007/s12185-017-2183-7. Epub 2017 Jan 21. Int J Hematol. 2017. PMID: 28110409
Cellular FLIP inhibits beta-catenin ubiquitylation and enhances Wnt signaling.
Naito M, Katayama R, Ishioka T, Suga A, Takubo K, Nanjo M, Hashimoto C, Taira M, Takada S, Takada R, Kitagawa M, Matsuzawa S, Reed JC, Tsuruo T. Naito M, et al. Among authors: hashimoto c. Mol Cell Biol. 2004 Oct;24(19):8418-27. doi: 10.1128/MCB.24.19.8418-8427.2004. Mol Cell Biol. 2004. PMID: 15367663 Free PMC article.
52 results